The slip
PARKINSON RECEIPTno. 15085
30 Oct 2026, 10:29 UTCdopamine neurons, braak
predictionFIBP in dopamine neurons tracks Braak Lewy-body stage
registeredff2b1a7e98b7a839
discovery+0.61 p=0.084 n=9
replication+0.28 p=0.459 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.61, p 0.084)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT7b056f2f3e4790aacc291014…
follows 09fa90943cf7…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15085: FIBP in dopamine neurons, braak
- power
- full sample +0.26 (p 0.306, n 18), 95% CI -0.24 to +0.65. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.27 (p 0.285, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.31 (p 0.214, n 18). could be the mix.
- skeptic
- leave-one-out range +0.14 to +0.37, sign flips 0; without severely affected donors +0.26 (p 0.306, n 18). fragile.
- cell type
- strongest in OPCs: -0.78 (p 1.3e-4, n 18) vs +0.26 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FIBP in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up FIBP · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.72 p 0.0100 (needs p < 1.5e-4)